MEDGENOME

In News

MedGenome Joins ORDI’s ‘Racefor7’ To Strengthen Awareness And Early Diagnosis Of Rare Diseases - BW Healthcare

BW Healthcare - Feb 12, 2026

MedGenome expands its infectious disease testing portfolio with MetaSeq - expresshealthcare.in

expresshealthcare.in - Feb 11, 2026

MedGenome raises Series E funding, co-led by Maj Invest and - Novo Holdings

Novo Holdings - Jul 21, 2025

MedGenome joins ORDI’s Annual Flagship Initiative "Racefor7" - healthcareexecutive.in

healthcareexecutive.in - Feb 13, 2026

MedGenome launches MetaSeq to detect over 1,400 pathogens in a single blood test - ET HealthWorld

ET HealthWorld - Feb 05, 2026

MedGenome expands infectious disease testing portfolio with MetaSeq - BioSpectrum India

BioSpectrum India - Feb 05, 2026

MedGenome Makes a Majority Investment in Leading Gujarat-Based Diagnostics Chain Green Cross to Expand Genomics Offerings Across India - Tribune India

Tribune India - Nov 04, 2025

MedGenome Launches MetaSeq Test To Detect Over 1,400 Pathogens From A Single Sample - IndiaMedToday

IndiaMedToday - Feb 10, 2026

MedGenome Expands Infectious Disease Testing Portfolio with Launch of MetaSeq - eHealth Magazine

eHealth Magazine - Feb 06, 2026

MedGenome Launches MetaSeq to Detect Over 1,400 Pathogens in a Single Blood Test - Digital Health News

Digital Health News - Feb 07, 2026

MedGenome Acquires Majority Stake in Green Cross Genetics Lab to Strengthen Diagnostic Reach - The Indian Practitioner

The Indian Practitioner - Nov 06, 2025

MedGenome Launches MetaSeq For Rapid Detection Of 1,400 Plus Bloodstream Pathogens - BW Healthcare

BW Healthcare - Feb 07, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment